HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tissue plasminogen activator and intravitreal gas for the treatment of Terson's syndrome: case report].

Abstract
The case of a 35 year-old male patient is reported. The patient had a clinical history of craniocerebral trauma and premacular hemorrhage of Terson syndrome in the left eye. After waiting for 45 days, without hemorrhage resolution, the patient received an intravitreal injection of sulfur hexafluoride gas and tPA; an almost complete hemorrhage absorption occurred after a week as well as a considerable improvement of visual acuity. In the report, relevant aspects of Terson syndrome and of intravitreal injection of gas and tPA are also described through a literature review.
AuthorsPedro Durães Serracarbassa, Luciana Duarte Rodrigues, Juliana Ribeiro Rodrigues
JournalArquivos brasileiros de oftalmologia (Arq Bras Oftalmol) 2009 May-Jun Vol. 72 Issue 3 Pg. 403-5 ISSN: 1678-2925 [Electronic] Brazil
Vernacular TitleAtivador do plasminogênio tecidual e gás intravítreo no tratamento da síndrome de Terson: relato de caso.
PMID19668978 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Tissue Plasminogen Activator
  • Sulfur Hexafluoride
Topics
  • Adult
  • Humans
  • Injections
  • Male
  • Retinal Hemorrhage (drug therapy, etiology)
  • Subarachnoid Hemorrhage, Traumatic (complications)
  • Sulfur Hexafluoride (therapeutic use)
  • Syndrome
  • Tissue Plasminogen Activator (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: